Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial

This study is currently recruiting participants.
Verified May 2013 by University of Medicine and Dentistry New Jersey
Sponsor:
Collaborators:
Children's Hospital Los Angeles
Columbia University
Emory University
Memorial Sloan-Kettering Cancer Center
Mount Sinai School of Medicine
Weill Medical College of Cornell University
Triad Interactive
National Marrow Donor Program
Information provided by (Responsible Party):
University of Medicine and Dentistry New Jersey
ClinicalTrials.gov Identifier:
NCT00939380
First received: July 14, 2009
Last updated: May 8, 2013
Last verified: May 2013
  Purpose

The investigators have developed a parent social-cognitive processing intervention (P-SCIP) to help decrease distress among parent caregivers of children undergoing hematopoietic stem cell transplant (HSCT). The investigators will evaluate the efficacy of P-SCIP in reducing short- and long-term distress and parenting stress among 300 parents of children undergoing HSCT. P-SCIP will be delivered during the child's inpatient HSCT hospitalization and is specifically designed to improve parent social (e.g., sharing concerns) and cognitive (e.g., acceptance) processing of the transplant experience. The intervention includes five in-person sessions that are accompanied by an interactive CD-ROM. The CD-ROM complements the materials in the in-person sessions and provides parents with the opportunity to enhance and deepen their cognitive and social processing of the HSCT experience. The intervention will be tested against best-practices psychosocial care (BPC) available in four enriched pediatric HSCT settings across the United States. P-SCIP will be provided to both Spanish- and English-speaking parents. Participants will complete measures of psychological distress, well-being, and social and cognitive processing at the time of HSCT, two, six and twelve months after HSCT. Research questions will address the effects of P-SCIP versus BPC on parent psychological adaptation and social and cognitive processing, as well as evaluate parent personal resources as well as child medical course variables that contribute to intervention response. The investigators will also examine barriers to participation in the intervention by comparing barriers to participation among parents who refuse participation in the trial and parents who accept.


Condition Intervention
Childhood Cancers
Behavioral: P-SCIP
Behavioral: BPC

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial

Resource links provided by NLM:


Further study details as provided by University of Medicine and Dentistry New Jersey:

Primary Outcome Measures:
  • Beck Depression Inventory [ Time Frame: Baseline, 1 month post-baseline, 6 mos post-baseline, 12 mos post-baseline ] [ Designated as safety issue: No ]
  • Beck Anxiety Inventory [ Time Frame: Baseline, 1 month post-baseline, 6 mos post-baseline, 12 mos post-baseline ] [ Designated as safety issue: No ]
  • Mental Health Inventory [ Time Frame: Baseline, 1 month post-baseline, 6 mos post-baseline, 12 mos post-baseline ] [ Designated as safety issue: No ]
  • Impact of Events Scale-Revised [ Time Frame: Baseline, 1 month post-baseline, 6 mos post-baseline, 12 mos post-baseline ] [ Designated as safety issue: No ]
  • Axis I Structured Clinical Interview for DSM-IV (SCID) [ Time Frame: Mood & Anxiety Modules at Baseline and 6 mo f/u; PTSD module at 6 mo f/u ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Fear Structure [ Time Frame: Baseline, 1 month post-baseline, 12 months post-baseline ] [ Designated as safety issue: No ]
  • Brief COPE [ Time Frame: Baseline, 1 month post-baseline, 12 mos post-baseline ] [ Designated as safety issue: No ]

Estimated Enrollment: 312
Study Start Date: August 2008
Estimated Study Completion Date: August 2013
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: P-SCIP
Consists of 5 60-minute counseling sessions. Sessions will begin immediately upon hospital admission. Session will occur over a three-week time span as some children are discharged 3 weeks after HSCT. The primary emphasis is learning how to engage in effective social and cognitive processing to deal with fears and worries about the transplant and transplant-related concerns.
Behavioral: P-SCIP
5 60-minute sessions with an interventionist
Experimental: BPC
BPC will consist of the available care at each site, a DVD and pamphlet describing psychological issues associated with HSCT and a booklet describing caregiver issues during HSCT and advice on how to handle them. An interventionist will meet with the parent to provide him/her with a walkie-talkie, description of five hours of respite care from a child life specialist, and a laptop to view the DVD.
Behavioral: BPC
Brief meeting with parent to provide BPC materials

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • biological or foster parent of children under 18 years of age who are scheduled for HSCT within the next month
  • participant is the primary caregiver
  • participant must have phone service
  • caregiver speaks, reads, and writes English or Spanish (Spanish is for Childrens Hospital Los Angeles and Columbia University only)

Exclusion Criteria:

  • pediatric patient has a diagnosis of medulloblastoma or other cancer of the brain
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00939380

Contacts
Contact: Tina M Gajda, M.A. 732-235-6472 gajdatm@umdnj.edu

Locations
United States, California
Childrens Hospital Los Angeles Recruiting
Los Angeles, California, United States, 90027
Contact: Octavio Zavala, B.S.     323-660-2450 ext 16362     ozavala@chla.usc.edu    
Contact: Brenda Quinonez-Garcia, M.S.W.     323-361-4933     BQuinonez@chla.usc.edu    
Principal Investigator: Ernest Katz, Ph.D.            
United States, Georgia
Emory University/Childrens Healthcare of Atlanta Recruiting
Atlanta, Georgia, United States, 30322
Contact: Maxson Bonnie, M.S.     404-785-1242     Bonnie.maxson@choa.org    
Principal Investigator: Mee Laura, Ph.D.            
United States, New Jersey
Umdnj Cinj Recruiting
New Brunswick, New Jersey, United States, 080903
Contact: Tina M Gajda, M.S.     732-235-6472     gajdatm@umdnj.edu    
Contact: Sharon Manne, PhD     732-235-6759     mannesl@umdnj.edu    
Principal Investigator: Sharon L Manne, Ph.D.            
United States, New York
Columbia University Recruiting
New York, New York, United States, 10032
Contact: Mirko Savone, BA         ms4750@columbia.edu    
Principal Investigator: Stephen Sands, Psy.D.            
Memorial Sloan-Kettering Cancer Center Recruiting
New York, New York, United States, 10021
Contact: Caraline Craig, B.A.     646-888-0131     craigc@mskcc.org    
Principal Investigator: Bartell Abraham, M.D., M.B.A.            
Sponsors and Collaborators
University of Medicine and Dentistry New Jersey
Children's Hospital Los Angeles
Columbia University
Emory University
Memorial Sloan-Kettering Cancer Center
Mount Sinai School of Medicine
Weill Medical College of Cornell University
Triad Interactive
National Marrow Donor Program
Investigators
Principal Investigator: Sharon L Manne, Ph.D. University of Medicine and Dentistry New Jersey
  More Information

No publications provided

Responsible Party: University of Medicine and Dentistry New Jersey
ClinicalTrials.gov Identifier: NCT00939380     History of Changes
Other Study ID Numbers: IRB#07-848; 15032-01, 1 R01 CA127488-01A1
Study First Received: July 14, 2009
Last Updated: May 8, 2013
Health Authority: United States: Institutional Review Board
United States: Federal Government

Keywords provided by University of Medicine and Dentistry New Jersey:
hematopoietic stem cell transplant
bone marrow transplant
children
parents
counseling
depression

ClinicalTrials.gov processed this record on June 17, 2013